Clinical Trials Browser

Phase 1/2 × Completed × Plasmacytoma × Clear all

NCT00421525 2021-08-16

Phase I/II Study of hLL1 in Multiple Myeloma

Phase 1/2 Completed

Multiple Myeloma, Plasmacytoma

NCT00821249 2020-10-19

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma, Paraproteinemias, Plasmacytoma

NCT00081757 2010-07-02

An Open Protocol for the Compassionate Use of Thalidomide

Phase 1/2 Completed

Multiple Myeloma, Plasmacytoma